Amneal Pharmaceuticals, Inc.
AMRX
$6.98
$0.010.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 112.42M | 77.26M | 47.22M | 48.46M | 93.74M |
| Total Receivables | 808.56M | 786.23M | 803.38M | 704.05M | 645.66M |
| Inventory | 612.45M | 596.36M | 575.62M | 570.65M | 581.38M |
| Prepaid Expenses | 46.50M | 49.11M | 53.41M | 51.79M | 49.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.87M | 4.34M | 5.85M | 5.10M | 7.57M |
| Total Current Assets | 1.59B | 1.51B | 1.49B | 1.38B | 1.38B |
|
|
|||||
| Total Current Assets | 1.59B | 1.51B | 1.49B | 1.38B | 1.38B |
| Net Property, Plant & Equipment | 523.69M | 532.90M | 528.94M | 544.79M | 550.14M |
| Long-term Investments | 597.44M | 598.32M | 598.53M | 598.55M | 598.63M |
| Goodwill | 597.44M | 598.32M | 598.53M | 598.55M | 598.63M |
| Total Other Intangibles | 732.38M | 780.19M | 819.94M | 859.27M | 890.42M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.21M | 18.34M | 24.57M | 21.12M | 18.43M |
| Total Assets | 3.50B | 3.46B | 3.51B | 3.46B | 3.47B |
|
|
|||||
| Total Accounts Payable | 259.84M | 236.92M | 201.78M | 176.98M | 145.53M |
| Total Accrued Expenses | 307.31M | 279.18M | 268.37M | 238.19M | 246.01M |
| Short-term Debt | 100.00M | 140.00M | 179.00M | 179.00M | 179.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 240.26M | 241.02M | 272.65M | 49.67M | 48.62M |
| Total Finance Division Other Current Liabilities | 222.36M | 198.08M | 192.56M | 190.56M | 227.43M |
| Total Other Current Liabilities | 222.36M | 198.08M | 192.56M | 190.56M | 227.43M |
| Total Current Liabilities | 1.13B | 1.10B | 1.11B | 834.39M | 846.60M |
|
|
|||||
| Total Current Liabilities | 1.13B | 1.10B | 1.11B | 834.39M | 846.60M |
| Long-Term Debt | 2.16B | 2.17B | 2.18B | 2.42B | 2.43B |
| Short-term Debt | 100.00M | 140.00M | 179.00M | 179.00M | 179.00M |
| Capital Leases | 91.09M | 94.03M | 95.92M | 97.56M | 95.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 163.33M | 135.81M | 126.14M | 121.45M | 41.77M |
| Total Liabilities | 3.55B | 3.49B | 3.51B | 3.47B | 3.41B |
|
|
|||||
| Common Stock & APIC | 563.31M | 556.33M | 548.80M | 541.81M | 542.31M |
| Retained Earnings | -607.06M | -575.98M | -575.83M | -581.82M | -490.18M |
| Treasury Stock & Other | -65.51M | -73.78M | -30.44M | -23.71M | -32.35M |
| Total Common Equity | -109.27M | -93.43M | -57.47M | -63.72M | 19.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -109.27M | -93.43M | -57.47M | -63.72M | 19.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 64.73M | 59.75M | 53.40M | 47.12M | 41.52M |
| Total Equity | -44.54M | -33.68M | -4.07M | -16.61M | 61.30M |
|
|
|||||
